E-Lab Notebook Flying High



By Kevin Davies

May 15, 2007 | Electronic lab notebooks (ELNs) play an important role in capturing and documenting troves of R&D information generated at scientists’ bench tops and desktops. But many ELNs, originally designed for chemistry applications, may not be suited for a biological workplace.

Columbus, Ohio-based Rescentris believes that its emphasis on biology first could pay dividends. It points to a flagship deployment at the Wright-Patterson Air Force Base in nearby Dayton, Ohio, where U.S. Air Force biologists and engineers have been early users of Rescentris’ CERF (Collaborative Electronic Research Framework) ELN. Last year, the collaboration won the award for best knowledge management platform for R&D from CENSA, the Collaborative Electronic Laboratory Notebook Systems Association. This year, CERF won a coveted “Best of Show” award at the Bio-IT World Expo.

Up in the Air
Adel Mikhail, Rescentris CEO, says the U.S. Air Force does a “huge amount of biological research, issues from basic biology to toxicology to other things. They have many thousands of investigators in R&D.” The Wright-Patterson base is expected to gain some 2,000 additional researchers over the next few years as a result of base closing consolidation.

In order to improve its data capture, documentation, and distribution of research, Wright-Patterson entrusted selection of its ELN to Christopher Geib, project engineer for Science Applications International Corporation (SAIC), a major government contractor. “There were redundancies in research,” says Geib. “There were sophisticated instruments generating copious quantities of information, producing only paper printouts or proprietary reports. Most importantly, there were lots and lots of paper notebooks. Anyone at any time might have books in their possession.”

Geib’s mission was to “take all those different silos of information, integrate them, and then bring them into the digital world.”

Andrea Stapleton, the molecular biologist/genomics laboratory manager at the Wright-Patterson laboratory, says there was a need for “one central repository where researchers could go — our collaborators, research assistants, PI’s — where they could put their data and organize it.”

Geib chose CERF over offerings from Waters and CambridgeSoft largely because of its potential extensibility and flexibility. “It was doing out of the box virtually everything we needed,” says Geib. “You’ve never seen anyone more excited about software than these guys, they were completely enamored,” says Mikhail.

CERF offers easy customization for a diverse range of activities and protocols, facilitated by its ontology-based design. “We could have a logistics CERF, an operations CERF — any number of different formats or designs,” says Geib. “It didn’t have to be just a biology CERF. When the ontology changes, CERF has the flexibility to function well in different environments.” 

Future Proof
CERF is “future proof,” says Mikhail. “It can be extended by the client. It’s built by biologists from the ground up, not a chemistry product trying to do biology.” He adds that it is “the only product of its kind built on ontologies. It’s completely compelling; they allow extensibility and modification of the software without writing a line of code.”

This has resulted in significant time-savings: results can be recorded directly into the ELN from the lab, and PI’s can review projects quickly. CERF also provides a means for scientists to share experimental data internally and with external partners.

CERF also helps keep track of work when a scientist leaves. Says Stapleton: “Typically when [a] person left a project, the paper data was archived and sometimes lost. With CERF we can easily access that data as we need it.”

“CERF has saved the government and U.S. taxpayers a lot of money,” says Geib. “Because we’re doing this electronically, the data integrity is better. Information doesn’t get lost.” CERF’s archiving feature allows Air Force staff to generate a single notebook that satisfies both military and federal government standards for archived records.

Rescentris hopes that its success with the U.S. Air Force and other government agencies including the CDC will bode well as it pushes into industry. “Pharma is a difficult industry,” Mikhail admits. “They have particular nuances that are difficult to penetrate; it’s a cumbersome sales cycle. But because we’ve won acclaim, they’ve come to us.” Several big pharmas are currently reviewing CERF, he says.

“The ELN market is about to explode,” says Mikhail. “This is the first time where the industry recognizes that to be competitive, they have to have an ELN. We are clearly the only product intended entirely for the biologist.”

Editor’s Note: This article is not an endorsement by the U.S. Air Force.

Subscribe to Bio-IT World  magazine.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .